GENTIBIO, INC.

Biotech · Private

Allogeneic engineered regulatory T cells (EngTregs) overexpressing ST2 for stroke recovery

Grants
$1.2M
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
40
0 granted · 40 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Development of Tissue Engineered Tregs as a Treatment for Acute Ischemic Stroke$1,150,417
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1098DARK MATTER THERAPEUTICS, INC.——
1099UFORCE BIOTECHNOLOGY, LLC——
1100PICCOLO BIOSYSTEMS, INC.——
1101GENTIBIO, INC.——
1102LUXBIOME INC——
1103Pattern Pharma Inc.—$1.2M
1104ANCHORCHEM LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 40
  • Compositions And Methods For Engineering Treg Cells For Treatment Of Diabetesapplication
  • Compositions And Methods For Engineering Stable Tregsapplication
  • Compositions And Methods For Controlling Cell Signaling With Chimeric Receptorsapplication
  • CD19 Car T Regulatory Cellsapplication
  • Membrane-anchored Nk Cell Inhibitory Receptor Engagersapplication
  • Membrane-anchored Nk Cell Inhibitory Receptor Engagersapplication
  • Regulatory T Cells Expressing Chimeric Antigen Receptorsapplication
  • Membrane-anchored Nk Cell Inhibitory Receptor Engagersapplication
  • Membrane-anchored Nk Cell Inhibitory Receptor Engagersapplication
  • CD19 Car T Regulatory Cellsapplication
  • CD19 Car T Regulatory Cellsapplication
  • CD19 Car T Regulatory Cellsapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.